Pacira BioSciences (PCRX) Shares Outstanding (Diluted Average) (2010 - 2026)

Pacira BioSciences' Shares Outstanding (Diluted Average) history runs 17 years deep, the most recent figure standing at $40.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 12.07% year-over-year to $40.9 million; the TTM figure through Mar 2026 stood at $40.9 million (down 12.07% YoY), while the FY2025 annual figure was $45.0 million, down 2.6% from the prior year.
• Shares Outstanding (Diluted Average) was $40.9 million for Q1 2026 at Pacira BioSciences, down from $45.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $52.5 million in Q2 2022 to a low of $40.9 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $47.4 million across 5 years, with a median of $46.3 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Diluted Average) grew 15.1% in 2022, then decreased 12.07% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $46.5 million in 2022, then grew by 11.69% to $52.0 million in 2023, then decreased by 11.03% to $46.2 million in 2024, then declined by 2.6% to $45.0 million in 2025, then dropped by 9.17% to $40.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $40.9 million (Q1 2026), $45.0 million (Q4 2025), and $44.5 million (Q3 2025), per Business Quant data.